Pat Cotroneo
2021
Compensation breakdown
| Non-Equity Incentive Plan | $187,718 |
|---|---|
| Option Awards | $1,845,874 |
| Salary | $515,000 |
| Stock Awards | $1,150,317 |
| Other | $57,824 |
| Total | $3,756,733 |
Cotroneo received $1.8M in option awards, accounting for 49% of the total pay in 2021.
Cotroneo also received $187.7K in non-equity incentive plan, $515K in salary, $1.2M in stock awards and $57.8K in other compensation.
Rankings
In 2021, Pat Cotroneo's compensation ranked 3,555th out of 12,415 executives tracked by ExecPay. In other words, Cotroneo earned more than 71.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,555 out of 12,415 | 71st |
Division Manufacturing | 1,456 out of 5,501 | 74th |
Major group Chemicals And Allied Products | 590 out of 2,374 | 75th |
Industry group Drugs | 527 out of 2,095 | 75th |
Industry Pharmaceutical Preparations | 368 out of 1,542 | 76th |
Pay ratio
| Pat Cotroneo's Pay | $3,756,733 |
|---|---|
| Median Employee's Pay | $174,414 |
| Pay Ratio | 22to 1 |
In 2021, the annual total compensation of Pat Cotroneo was $3,756,733.
The annual total compensation of the median employee at FibroGen was $174,414.
The ratio of Pat Cotroneo's pay to the pay of median employee was therefore 22 to one.
Cotroneo's colleagues
We found six more compensation records of executives who worked with Pat Cotroneo at FibroGen in 2021.
2021
Enrique Conterno
FibroGen
Chief Executive Officer
2021
Christine Chung
FibroGen
Senior Vice President, China Operations
2021
Mark Eisner
FibroGen
Chief Medical Officer
2021
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
2021
Thane Wettig
FibroGen
Chief Commercial Officer
2021
Juan Graham
FibroGen